"Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013" Published

Global Market Direct's pharmaceuticals report, "Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013" provides data on the Kyorin Pharmaceutical Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Kyorin Pharmaceutical Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Kyorin Pharmaceutical Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- http://www.fastmr.com/prod/647090_kyorin_pharmaceutical_co_ltd_product_pipeline.aspx?afid=301

Scope

* Kyorin Pharmaceutical Co., Ltd. - Brief Kyorin Pharmaceutical Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Kyorin Pharmaceutical Co., Ltd. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Kyorin Pharmaceutical Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Kyorin Pharmaceutical Co., Ltd.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate Kyorin Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Kyorin Pharmaceutical Co., Ltd. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Kyorin Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Kyorin Pharmaceutical Co., Ltd..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Kyorin Pharmaceutical Co., Ltd. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Kyorin Pharmaceutical Co., Ltd.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2013
- Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012
- Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Chong Kun Dang Pharmaceutical Corp. - Product Pipeline Review - 2013